Tom Boyles to Tuberculosis, Pulmonary
This is a "connection" page, showing publications Tom Boyles has written about Tuberculosis, Pulmonary.
Connection Strength
0,999
-
Why do clinical trials of Xpert® MTB/RIF fail to show an effect on patient relevant outcomes? Int J Tuberc Lung Dis. 2017 03 01; 21(3):249-250.
Score: 0,442
-
False-positive Xpert(®) MTB/RIF assays and previous treatment. Int J Tuberc Lung Dis. 2015 Apr; 19(4):495-6.
Score: 0,387
-
Clinical utility of WHO-recommended screening tools and development and validation of novel clinical prediction models for pulmonary tuberculosis screening among outpatients living with HIV: an individual participant data meta-analysis. Eur Respir Rev. 2023 Jun 30; 32(168).
Score: 0,171